Regulus Therapeutics Inc. (RGLS) Ownership

$7.85

$0.01 (0.13%)
Last update: 04:00 PM EST
Day's range
$7.83
Day's range
$7.86

Regulus Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FEDERATED HERMES, INC. 02/13/2025 12.85 M $20.31 M   0.00% 19.63%
NEA MANAGEMENT COMPANY, LLC 02/14/2025 6.47 M $10.22 M   0.00% 9.88%
VIVO CAPITAL, LLC 02/13/2025 5.00 M $7.90 M   0.00% 7.64%
OCTAGON CAPITAL ADVISORS LP 02/14/2025 4.85 M $7.66 M   13.72% 7.41%
BLACKROCK, INC. 02/07/2025 4.24 M $6.69 M   3.81% 6.47%
VANGUARD GROUP INC 02/11/2025 3.97 M $6.27 M   -2.98% 6.06%
DEEP TRACK CAPITAL, LP 02/14/2025 3.26 M $5.15 M   0.00% 4.98%
MILLENNIUM MANAGEMENT LLC 02/14/2025 2.19 M $3.46 M   69.75% 3.35%
ADAGE CAPITAL PARTNERS GP, L.L.C. 02/14/2025 2.00 M $3.16 M   0.00% 3.05%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 1.28 M $2.02 M   -0.10% 1.95%
STATE STREET CORP 02/14/2025 1.06 M $1.67 M   5.54% 1.61%
ALYESKA INVESTMENT GROUP, L.P. 02/14/2025 1.04 M $1.64 M   0.00% 1.58%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 895.13 K $1.41 M   0.15% 1.37%
DAFNA CAPITAL MANAGEMENT LLC 02/14/2025 875.20 K $1.38 M   -2.23% 1.34%
NORTHERN TRUST CORP 02/14/2025 457.23 K $722.43 K   -8.06% 0.70%
VICTORY CAPITAL MANAGEMENT INC 02/06/2025 389.89 K $616.02 K   -2.25% 0.60%
RA CAPITAL MANAGEMENT, L.P. 02/14/2025 336.84 K $532.21 K   -56.07% 0.51%
GOLDMAN SACHS GROUP INC 02/11/2025 212.38 K $335.56 K   18.64% 0.32%
JPMORGAN CHASE & CO 02/12/2025 190.46 K $300.92 K   141.17% 0.29%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 178.88 K $282.63 K   0.00% 0.27%
CITADEL ADVISORS LLC 02/14/2025 155.56 K $245.78 K   486,018.75% 0.24%
BANK OF NEW YORK MELLON CORP 02/04/2025 149.36 K $235.98 K   0.00% 0.23%
MORGAN STANLEY 02/14/2025 139.79 K $220.87 K   -16.83% 0.21%
RENAISSANCE TECHNOLOGIES LLC 02/13/2025 117.10 K $185.02 K   20.47% 0.18%
TYCHE WEALTH PARTNERS LLC 01/27/2025 106.09 K $167.62 K   0.00% 0.16%
BARCLAYS PLC 02/13/2025 96.25 K $152.00 K   13.93% 0.15%
UBS GROUP AG 02/14/2025 90.15 K $142.43 K   201.74% 0.14%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 85.60 K $135.25 K   0.00% 0.13%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 02/14/2025 70.00 K $110.60 K   100.00% 0.11%
PEAK6 LLC 02/13/2025 60.00 K $94.80 K   100.00% 0.09%
RHUMBLINE ADVISERS 01/30/2025 59.53 K $94.05 K   -20.09% 0.09%
BANK OF AMERICA CORP /DE/ 02/14/2025 53.84 K $85.07 K   -1.08% 0.08%
CITIGROUP INC 02/12/2025 50.14 K $79.22 K   -6.69% 0.08%
LPL FINANCIAL LLC 02/11/2025 49.98 K $78.97 K   -13.80% 0.08%
NEW YORK STATE COMMON RETIREMENT FUND 01/31/2025 49.40 K $78.00 K   0.00% 0.08%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 36.70 K $57.99 K   4.40% 0.06%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 36.19 K $57.18 K   100.00% 0.06%
WELLS FARGO & COMPANY/MN 02/13/2025 35.16 K $55.55 K   32.25% 0.05%
COREBRIDGE FINANCIAL, INC. 02/11/2025 31.40 K $49.61 K   -7.02% 0.05%
INVESCO LTD. 02/13/2025 30.25 K $47.79 K   7.06% 0.05%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 29.60 K $47.00 K   -98.62% 0.05%
INTECH INVESTMENT MANAGEMENT LLC 02/11/2025 28.48 K $45.00 K   100.00% 0.04%
ALLIANCEBERNSTEIN L.P. 02/12/2025 26.88 K $42.47 K   0.00% 0.04%
SG AMERICAS SECURITIES, LLC 01/17/2025 26.46 K $42.00 K   27.21% 0.04%
VOYA INVESTMENT MANAGEMENT LLC 05/02/2025 23.07 K $36.46 K   0.00% 0.04%
TWO SIGMA INVESTMENTS, LP 02/14/2025 22.26 K $35.18 K   16.07% 0.03%
PROSHARE ADVISORS LLC 02/14/2025 17.79 K $28.10 K   49.05% 0.03%
CREATIVE PLANNING 02/14/2025 14.12 K $22.30 K   -14.27% 0.02%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 13.70 K $21.65 K   -62.36% 0.02%
02/11/2025 12.70 K $20.06 K   100.00% 0.02%

Regulus Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 40 institutional investors and hedge funds held shares of Regulus Therapeutics Inc.. The most heavily invested institutionals were:

COMMONWEALTH EQUITY SERVICES, LLC: 0

PEAK6 LLC: 0

Continuum Advisory, LLC: 0

Octagon Capital Advisors LP: 4.85 M

Deep Track Capital, LP: 3.26 M

MILLENNIUM MANAGEMENT LLC: 2.19 M

81.73% of Regulus Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 21.91 M shares in the last 24 months. This purchase volume represents approximately $172.01 M in transactions.